| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Charles E Sheedy last filed a Form 4 in July 2025, as 10% Owner at AURX. Charles E Sheedy's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 11,570,833 shares of AURX. Net of sales, the AURX filings show accumulation of 6,595,701 shares.
Charles E Sheedy has 8 Form 4 filings on record from June 2016 to July 2025, all as 10% Owner at Nuo Therapeutics (AURX), 2016–2025.
The 8 reported transactions were 7 open-market purchases and 1 other transaction.
Counted by filing, the open-market trades come to 7 purchases worth about $2.5M and no sales.
The largest open-market purchase was 5,220,000 shares of AURX at an average $0.22 on August 10, 2017, about $1.2M.
Shares as reported in the last Form 4 for each company; the most recent is from July 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2025 | AURX Nuo Therapeutics, Inc. | 10% Owner | Buy | 133,333 | $1.50 | $199,999.50 | +1.2% | |
| Sep 18, 2024 | AURX Nuo Therapeutics, Inc. | 10% Owner | Buy | 125,000 | $0.75 | $93,750.00 | +1.1% | |
| May 20, 2024 | AURX Nuo Therapeutics, Inc. | 10% Owner | Buy | 100,000 | $0.75 | $75,000.00 | +0.9% | |
| Dec 19, 2023 | AURX Nuo Therapeutics, Inc. | 10% Owner | Buy | 150,000 | $0.50 | $75,000.00 | +1.4% | |
| Aug 1, 2023 | AURX Nuo Therapeutics, Inc. | 10% Owner | Buy | 62,500 | $2.00 | $125,000.00 | +0.6% | |
| Apr 29, 2022 | AURX Nuo Therapeutics, Inc. | 10% Owner | Buy | 804,868 | $1.00 | $804,868.00 | +7.9% | |
| Aug 10, 2017 | AURX Nuo Therapeutics, Inc. | 10% Owner | Buy | 5,220,000 | $0.22 | $1,159,884.00 | +170.2% |